Share this post:

Writing for Reuters, Ben Hirschler covers the Foundation’s new white paper on antibiotic shortages: “Most antibiotics are cheap, off-patent generic medicines, which is good for affordability. But that also means they have very low profit margins – particularly compared to modern drugs for diseases like cancer – offering manufacturers little incentive to invest in new production facilities, looking at the market factors that.”

Read Full Article